BiondVax Pharmaceuticals Ltd. (BVXV) Social Stream
BIONDVAX PHARMACEUTICALS LTD (BVXV) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIONDVAX PHARMACEUTICALS LTD.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued December 8, 2022
BVXV reports an average of 3,363.17% for its upside potential over the past 77 days.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
BVXV Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
BVXV's average broker recommendation rating improved by 0 over the prior 48 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BVXV as an investment opportunity.
- BIONDVAX PHARMACEUTICALS LTD's number of analysts covering the stock is greater than practically none of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, BIONDVAX PHARMACEUTICALS LTD's upside potential (average analyst target price relative to current price) is higher than 387.01% of them.
- BIONDVAX PHARMACEUTICALS LTD's average analyst price target is greater than 233.68% of stocks in the small market cap category.
- BIONDVAX PHARMACEUTICALS LTD's variance in analysts' estimates is lower than 16.49% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, DBVT, EIGR, and OCGN are the three stocks most similar to BIONDVAX PHARMACEUTICALS LTD regarding the price target and analyst recommendation information presented here.
Is BVXV a Buy, Hold or Sell? See the POWR Ratings now!